Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Buy
69
PSNL Quote, Financials, Valuation and Earnings
Last price:
$5.70
Seasonality move
:
-17.16%
Day range:
$5.74 - $6.56
52-week range:
$1.12 - $7.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.63x
P/B ratio:
2.52x
Volume:
1.6M
Avg. volume:
1.2M
1-year change:
306.14%
Market cap:
$420.4M
Revenue:
$73.5M
EPS (TTM):
-$1.68
Analysts' Opinion
-
Consensus RatingPersonalis has received a consensus rating of . The company's average rating is a based on 3 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $7.58, Personalis has an estimated upside of 27.46% from its current price of $5.95.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $5.00 representing 100% downside risk from its current price of $5.95.
Fair Value
-
According to the consensus of 0 analysts, Personalis has 27.46% upside to fair value with a price target of $7.58 per share.
PSNL vs. S&P 500
-
Over the past 5 trading days, Personalis has overperformed the S&P 500 by 57.64% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Personalis does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Personalis has grown year-over-year revenues for 5 quarters straight. In the most recent quarter Personalis reported revenues of $25.7M.
Earnings Growth
-
Personalis has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Personalis reported earnings per share of -$0.64.
Enterprise value:
278.4M
EV / Invested capital:
1.65x
Price / LTM sales:
3.63x
EV / EBIT:
--
EV / Revenue:
3.18x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-5.09x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$27.5M
Return On Assets:
-42.64%
Net Income Margin (TTM):
-104.52%
Return On Equity:
-67.2%
Return On Invested Capital:
-66.46%
Operating Margin:
-55.94%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $69M | $70.5M | $87.5M | $18.2M | $25.7M | |
| Gross Profit | $19M | $15.3M | $27.5M | $3.5M | $8.7M | |
| Operating Income | -$103.7M | -$108.4M | -$70.1M | -$25.2M | -$14.4M | |
| EBITDA | -$95.1M | -$101.2M | -$80.1M | -$26.3M | -$36.3M | |
| Diluted EPS | -$2.26 | -$2.38 | -$1.68 | -$0.60 | -$0.64 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $223.6M | $329M | $221.9M | $148.2M | $170.3M | |
| Total Assets | $248.8M | $406.7M | $317.9M | $226.6M | $239.9M | |
| Current Liabilities | $35.9M | $26.5M | $33.7M | $32.5M | $36.4M | |
| Total Liabilities | $45.3M | $81.4M | $75.5M | $75.4M | $73.1M | |
| Total Equity | $203.5M | $325.3M | $242.4M | $151.2M | $166.8M | |
| Total Debt | -- | $3.4M | $2.5M | $403K | $1.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$68.7M | -$59.6M | -$50.8M | -$16.7M | -$6.2M | |
| Cash From Investing | $70.6M | $46.6M | -$20.5M | -$8.6M | -$28.2M | |
| Cash From Financing | $2.2M | $1.7M | $74.9M | $290K | $62.4M | |
| Free Cash Flow | -$112.7M | -$76.5M | -$54.7M | -$17.5M | -$6.4M | |
PSNL
Sector
Market Cap
$420.4M
$45.6M
Price % of 52-Week High
82.64%
45.55%
Dividend Yield
0%
0%
Shareholder Yield
-12.87%
-0.74%
1-Year Price Total Return
306.14%
-31.35%
Beta (5-Year)
1.877
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$4.43
200-day SMA
Buy
Level
$3.17
Bollinger Bands (100)
Buy
Level
3.92 - 5.58
Chaikin Money Flow
Sell
Level
-22.5M
20-day SMA
Buy
Level
$4.10
Relative Strength Index (RSI14)
Buy
Level
70.77
ADX Line
Buy
Level
19.93
Williams %R
Neutral
Level
-32.376
50-day SMA
Buy
Level
$4.41
MACD (12, 26)
Buy
Level
0.22
25-day Aroon Oscillator
Buy
Level
80
On Balance Volume
Neutral
Level
43M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.9781)
Sell
CA Score
(Annual)
Level (-1.4502)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (3.0893)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Stock Forecast FAQ
In the current month, PSNL has received 3 Buy ratings 1 Hold ratings, and 0 Sell ratings. The PSNL average analyst price target in the past 3 months is $7.58.
-
Where Will Personalis Stock Be In 1 Year?
According to analysts, the consensus estimate is that Personalis share price will rise to $7.58 per share over the next 12 months.
-
What Do Analysts Say About Personalis?
Analysts are divided on their view about Personalis share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Personalis is a Sell and believe this share price will drop from its current level to $5.00.
-
What Is Personalis's Price Target?
The price target for Personalis over the next 1-year time period is forecast to be $7.58 according to 0 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is PSNL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Personalis is a . 0 of 0 analysts rate the stock a at this time.
-
How Can I Buy Shares Of PSNL?
You can purchase shares of Personalis via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Personalis shares.
-
What Is The Personalis Share Price Today?
Personalis was last trading at $5.70 per share. This represents the most recent stock quote for Personalis. Yesterday, Personalis closed at $5.95 per share.
-
How To Buy Personalis Stock Online?
In order to purchase Personalis stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 7.34% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.76% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.68% over the past day.
